Purpose: To evaluate the safety and feasibility of ureteroscopy plus elective double-J stent as an outpatient procedure in an unselected population with regard to the treatment for ureteral calculi and to present a multivariate analysis of factors predict hospitalization. Materials and Methods: Ureteroscopy was performed as an outpatient procedure on 308 consecutive patients with ureteral stones. Contraindication for day case surgery was the only exclusion criteria from the study. All causes that led to immediate hospitalization were recorded; at the same time, all causes of hospitalization that occurred within 72 h from the procedure were also recorded and included in the final analysis. Results: The overall stone-free rate and the rate of hospitalization were 94.5 and 9.7% respectively. Intraoperative complications were observed in 16 patients (5.1%). In terms of the variables related to hospitalization, the univariate analysis showed a statistical significant association between the American Society of Anesthesiologists (ASA) score (p < 0.001) and operative time (p = 0.018). At multivariate analysis, the only independent factor predictor of hospitalization was the ASA score (p < 0.001). Conclusions: In our experience, semirigid ureteroscopy is a safe and effective treatment that is independent of intraoperative local conditions or stone size. Elective Double-J stenting avoids major complications as the first reason for hospitalization. We suggest that ASA score > 2 should be taken into account when ureterorenoscopy is planning as an outpatient procedure.

Keywords:
Ureteroscopy, Stone disease, Outpatient surgery, Endourology
1.
Ramello A, Vitale C, Marangella M: Epidemiology of nephrolithiasis. J Nephrol 2000; 13(suppl 3):S45–S50.
2.
Stamatelou KK, Francis ME, Jones CA, et al: Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 2003; 63: 1817–1823.
3.
Türk C, Petřík A, Sarica K, et al: EAU guidelines on interventional treatment for urolithiasis. Eur Urol 2016; 69: 475–482.
4.
Aboumarzouk OM, Kata SG, Keeley FX, et al: Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev 2012; 5:CD006029.
5.
Geavlete P, Georgescu D, Nita G, et al: Complications of 2735 retrograde semirigid ureteroscopy procedures: a single-center experience. J Endourol 2006; 20: 179–185.
6.
Perez Castro E, Osther PJ, Jinga V, et al: Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the clinical research office of the endourological society ureteroscopy global study. Eur Urol 2014; 66: 102–109.
7.
Crew JP, Turner KJ, Millar J, et al: Is day case surgery in urology associated with high admission rates? Ann R Coll Surg Engl 1997; 79: 416–419.
8.
Cullen KA, Hall MJ, Golosinskiy A: Ambulatory surgery in the United States, 2006. Natl Health Stat Report 2009; 11: 1–25.
9.
Wills TE, Burns JR: Ureteroscopy: an outpatient procedure? J Urol 1994; 151: 1185–1187.
10.
Yip KH, Lee CW, Tam PC: Holmium laser lithotripsy for ureteral calculi: an outpatient procedure. J Endourol 1998; 12: 241–246.
11.
Cheung MC, Lee F, Leung YL, et al: Outpatient ureteroscopy: predictive factors for postoperative events. Urology 2001; 58: 914–918.
12.
Mull HJ, Rosen AK, O’Brien WJ, et al: Factors associated with ospital admission after outpatient surgery in the veterans health administration. Health Serv Res 2018; 53: 3855–3880.
13.
Mandal S, Goel A, Singh MK, et al: Clavien classification of semirigid ureteroscopy complications: a prospective study. Urology 2012; 80: 995–1001.
14.
Tan HJ, Strope SA, He C, et al: Immediate unplanned hospital admission after outpatient ureteroscopy for stone disease. J Urol 2011; 185: 2181–2185.
15.
Molina Escudero R, Gonzalez Avila N, Alvarez Ardura M, et al: Predictors of success and hospitalization in semi-rigid ureteroscopy for lithiasis as an outpatient procedure. Arch Esp Urol 2013; 66: 865–872.
16.
Tang L, Gao X, Xu B, et al: Placement of ureteral stent after uncomplicated ureteroscopy: do we really need it? Urology 2011; 78: 1248–1256.
17.
Coley KC, Williams BA, DaPos SV, Chen C, Smith RB: Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth 2002; 14: 349–353.
18.
Association of Anaesthetists of Great Britain and Ireland, British Association of Day Surgery: Day case and short stay surgery: 2. Anaesthesia 2011; 66: 417–434.
19.
Maciejewski D; Committee on Ambulatory Anaesthesia, Polish Society of Anaesthesiology and Intensive Therapy: Guidelines for system and anaesthesia organisation in short stay surgery (ambulatory anaesthesia, anaesthesia in day case surgery). Anaesthesiol Intensive Ther 2013; 45: 190–199.
20.
Oitchayomi A, Doerfler A, Le Gal S, et al: Flexible and rigid ureteroscopy in outpatient surgery. BMC Urol 2016; 16: 6.
21.
Rambachan A, Matulewicz RS, Pilecki M, Kim JY, Kundu SD: Predictors of readmission following outpatient urological surgery. J Urol 2014; 192: 183–188.
22.
Damiano R, Autorino R, Esposito C, et al: Stent positioning after ureteroscopy for urinary calculi: the question is still open. Eur Urol 2004; 46: 381–387.
23.
Netto NR Jr, Ikonomidis J, Zillo C: Routine ureteral stenting after ureteroscopy for ureteral lithiasis: is it really necessary? J Urol 2001; 166: 1252–1254.
24.
Pais VM Jr, Smith RE, Stedina EA, et al: Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol 2016; 196: 1458–1466.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.